SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-14-002464
Filing Date
2014-08-14
Accepted
2014-08-14 06:22:08
Documents
5
Period of Report
2014-08-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vsta8k_aug142014.htm 8-K 22374
2 CERTIFICATE OF CHANGE OF VISTAGEN THERAPEUTICS, INC., FILED AUGUST 11, 2014 ex3-1.htm EX-3.1 528
3 PRESS RELEASE, DATED AUGUST 13, 2014 ex99-1.htm EX-99.1 13374
4 vsta.jpg GRAPHIC 6129
5 page1.jpg GRAPHIC 419476
  Complete submission text file 0001415889-14-002464.txt   624074
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54014 | Film No.: 141039356
SIC: 2834 Pharmaceutical Preparations